What is the share price of Jupiter Life Line Hospitals Ltd (JLHL) today?
The share price of JLHL as on 23rd March 2026 is ₹1254.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Jupiter Life Line Hospitals Ltd (JLHL) share?
The past returns of Jupiter Life Line Hospitals Ltd (JLHL) share are- Past 1 week: 1.67%
- Past 1 month: 4.11%
- Past 3 months: -9.45%
- Past 6 months: -14.15%
- Past 1 year: -22.43%
- Past 3 years: N/A%
- Past 5 years: 17.95%
What are the peers or stocks similar to Jupiter Life Line Hospitals Ltd (JLHL)?
The peers or stocks similar to Jupiter Life Line Hospitals Ltd (JLHL) include:What is the dividend yield % of Jupiter Life Line Hospitals Ltd (JLHL) share?
The current dividend yield of Jupiter Life Line Hospitals Ltd (JLHL) is 0.08.What is the market cap of Jupiter Life Line Hospitals Ltd (JLHL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jupiter Life Line Hospitals Ltd (JLHL) is ₹8410.15 Cr as of 23rd March 2026.What is the 52 week high and low of Jupiter Life Line Hospitals Ltd (JLHL) share?
The 52-week high of Jupiter Life Line Hospitals Ltd (JLHL) is ₹1770 and the 52-week low is ₹1198.80.What is the PE and PB ratio of Jupiter Life Line Hospitals Ltd (JLHL) stock?
The P/E (price-to-earnings) ratio of Jupiter Life Line Hospitals Ltd (JLHL) is 43.46. The P/B (price-to-book) ratio is 6.20.Which sector does Jupiter Life Line Hospitals Ltd (JLHL) belong to?
Jupiter Life Line Hospitals Ltd (JLHL) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Jupiter Life Line Hospitals Ltd (JLHL) shares?
You can directly buy Jupiter Life Line Hospitals Ltd (JLHL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Jupiter Life Line Hospitals Ltd
JLHL Share Price
NSE₹1,254.601.13% (-14.30)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
JLHL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
JLHL Performance & Key Metrics
JLHL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 44.58 | 6.20 | 0.08% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.10 | 5.54 | 0.61% |
100%
Analysts have suggested that investors can buy this stock
from 5 analysts
Price Upside
Earnings Growth
Rev. Growth
JLHL Company Profile
Jupiter Life Line Hospitals Ltd operates multi-specialty hospitals in India, offering over 30 specialty treatments and promoting medical tourism.
APOLLOHOSP
PE Ratio
72.12
72.12
1Y Return
13.75%
13.75%
Buy Reco %
86.21
86.21
MAXHEALTH
PE Ratio
86.21
86.21
1Y Return
15.06%
15.06%
Buy Reco %
81.82
81.82
FORTIS
PE Ratio
79.80
79.80
1Y Return
31.04%
31.04%
Buy Reco %
82.35
82.35
PE Ratio
42.37
42.37
1Y Return
1.99%
1.99%
Buy Reco %
80.00
80.00
ASTERDM
PE Ratio
6.12
6.12
1Y Return
44.64%
44.64%
Buy Reco %
100.00
100.00
JLHL Sentiment Analysis
JLHL Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
JLHL Stock Summary · February 2026
The company demonstrated operational momentum with a year-on-year increase in total income and EBITDA, despite facing challenges such as a decrease in profit after tax due to a one-time provision related to the new Labor Code. The successful completion of the Dombivli hospital project ahead of schedule presents a long-term growth opportunity, although initial operations are expected to incur losses and higher depreciation expenses. As construction progresses on the Pune Bibvewadi project, the company remains focused on expanding into underserved markets in Western India, leveraging local healthcare needs. However, workforce challenges persist, particularly in smaller regions, necessitating a strategic approach to doctor retention and compensation. Overall, while the financial outlook is tempered by regulatory pressures and economic factors, the demand for healthcare services continues to outpace supply, supporting a positive trajectory for future growth.
JLHL Stock Growth Drivers
JLHL Stock Growth Drivers
7Successful Hospital Launch
The company successfully completed the construction of a new 500-bed hospital in Dombivli ahead of
Positive Financial Metrics
The company reported a year-over-year growth in Average Revenue Per Occupied Bed (ARPOB), increasing from
JLHL Stock Challenges
JLHL Stock Challenges
5Decline in Profit After Tax (PAT)
The company reported a significant decrease in profit after tax (PAT) for the current quarter,
Increased Depreciation Expenses
The company anticipates a significant increase in depreciation expenses starting next quarter, which is expected
JLHL Forecast
JLHL Forecasts
Price
Revenue
Earnings
JLHL Share Price Forecast
JLHL Share Price Forecast
2026
Current
₹1,268.90
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹1,268.90
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
JLHL Company Revenue Forecast
JLHL Company Revenue Forecast
2025
Current
₹1.29
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.29
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
JLHL Stock EPS (Earnings Per Share) Forecast
JLHL Stock EPS (Earnings Per Share) Forecast
2025
Current
₹29.52
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹29.52
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
JLHL
JLHL
Income
Balance Sheet
Cash Flow
Quarterly Normal View
JLHL Income Statement
JLHL Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 267.14 | 280.67 | 301.72 | 295.50 | 342.46 | 340.02 | 333.77 | 365.77 | 404.90 | 374.50 | ||||||||||
Operating & Other expenses | 202.92 | 210.91 | 228.21 | 223.27 | 256.83 | 256.47 | 248.49 | 274.53 | 301.38 | 288.34 | ||||||||||
EBITDA | 64.22 | 69.76 | 73.51 | 72.23 | 85.63 | 83.55 | 85.28 | 91.24 | 103.52 | 86.16 | ||||||||||
| Depreciation/Amortization | 10.62 | 10.65 | 10.39 | 11.00 | 14.42 | 13.99 | 17.62 | 21.22 | 21.46 | 21.70 | ||||||||||
| PBIT | 53.60 | 59.11 | 63.12 | 61.23 | 71.21 | 69.56 | 67.66 | 70.02 | 82.06 | 64.46 | ||||||||||
| Interest & Other Items | 12.23 | 1.03 | 0.93 | 1.08 | 1.16 | 2.82 | 5.57 | 8.27 | 7.84 | 7.55 | ||||||||||
| PBT | 41.37 | 58.08 | 62.19 | 60.15 | 70.05 | 66.74 | 62.09 | 61.75 | 74.22 | 56.91 | ||||||||||
| Taxes & Other Items | 7.69 | 14.42 | 17.14 | 15.68 | 18.40 | 14.65 | 17.24 | 17.86 | 16.86 | 14.35 | ||||||||||
| Net Income | 33.68 | 43.66 | 45.05 | 44.47 | 51.65 | 52.09 | 44.85 | 43.89 | 57.36 | 42.56 | ||||||||||
| EPS | 5.67 | 6.56 | 6.49 | 6.80 | 7.88 | 7.95 | 6.84 | 6.69 | 8.75 | 6.49 |
JLHL Company Updates
FY 2026FY 2026
Investor Presentation
Jan 31PDF
Jan 30PDF
Nov 7PDF
Aug 1PDF
JLHL Stock Peers
JLHL Past Performance & Peer Comparison
JLHL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Jupiter Life Line Hospitals Ltd | 43.46 | 6.20 | 0.08% |
| Apollo Hospitals Enterprise Ltd | 72.12 | 9.40 | 0.17% |
| Max Healthcare Institute Ltd | 86.21 | 9.89 | 0.16% |
| Fortis Healthcare Ltd | 79.80 | 6.74 | 0.12% |
JLHL Stock Price Comparison
Compare JLHL with any stock or ETFCompare JLHL with any stock or ETF
JLHL
JLHL Holdings
JLHL Shareholdings
JLHL Promoter Holdings Trend
JLHL Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
JLHL Institutional Holdings Trend
JLHL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
JLHL Shareholding Pattern
JLHL Shareholding Pattern
JLHL Shareholding History
JLHL Shareholding History
Foreign Institutions
Mutual Funds Invested in JLHL
Mutual Funds Invested in JLHL
No mutual funds holding trends are available
Top 5 Mutual Funds holding Jupiter Life Line Hospitals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 6.2966% | Percentage of the fund’s portfolio invested in the stock 2.31% | Change in the portfolio weight of the stock over the last 3 months -0.28% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/69 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.3503% | Percentage of the fund’s portfolio invested in the stock 2.79% | Change in the portfolio weight of the stock over the last 3 months -0.42% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 20/39 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.5768% | Percentage of the fund’s portfolio invested in the stock 0.74% | Change in the portfolio weight of the stock over the last 3 months -0.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 34/95 (-4) |
Compare 3-month MF holding change on Screener
smallcases containing JLHL stock
smallcases containing JLHL stock
Looks like this stock is not in any smallcase yet.
JLHL Events
JLHL Events
JLHL Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
JLHL Dividend Trend
No dividend trend available
JLHL Upcoming Dividends
JLHL Upcoming Dividends
No upcoming dividends are available
JLHL Past Dividends
JLHL Past Dividends
Cash Dividend
Ex DateEx DateJul 4, 2025
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 4, 2025
Cash Dividend
Ex DateEx DateAug 2, 2024
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 2, 2024
JLHL Stock News & Opinions
JLHL Stock News & Opinions
Articles & Videos
Earnings
Jupiter Life Line Hospitals consolidated net profit declines 18.31% in the December 2025 quarter
Net profit of Jupiter Life Line Hospitals declined 18.31% to Rs 42.55 crore in the quarter ended December 2025 as against Rs 52.09 crore during the previous quarter ended December 2024. Sales rose 9.78% to Rs 365.37 crore in the quarter ended December 2025 as against Rs 332.81 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales365.37332.81 10 OPM %22.8322.94 - PBDT85.0180.72 5 PBT63.3166.73 -5 NP42.5552.09 -18 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Jupiter Life Line Hospitals to table results
Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Jupiter Life Line Hospitals consolidated net profit rises 11.04% in the September 2025 quarter
Net profit of Jupiter Life Line Hospitals rose 11.04% to Rs 57.35 crore in the quarter ended September 2025 as against Rs 51.65 crore during the previous quarter ended September 2024. Sales rose 17.48% to Rs 393.63 crore in the quarter ended September 2025 as against Rs 335.05 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales393.63335.05 17 OPM %23.4423.35 - PBDT95.6884.46 13 PBT74.2270.04 6 NP57.3551.65 11 Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Jupiter Life Line Hospitals standalone net profit rises 8.55% in the September 2025 quarter
Net profit of Jupiter Life Line Hospitals rose 8.55% to Rs 54.60 crore in the quarter ended September 2025 as against Rs 50.30 crore during the previous quarter ended September 2024. Sales rose 14.82% to Rs 315.82 crore in the quarter ended September 2025 as against Rs 275.06 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales315.82275.06 15 OPM %24.9525.96 - PBDT87.1677.70 12 PBT70.4867.29 5 NP54.6050.30 9 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Jupiter Life Line Hospitals announces board meeting date
Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Jupiter Life Line Hospitals consolidated net profit declines 1.42% in the June 2025 quarter
Net profit of Jupiter Life Line Hospitals declined 1.42% to Rs 43.84 crore in the quarter ended June 2025 as against Rs 44.47 crore during the previous quarter ended June 2024. Sales rose 20.46% to Rs 347.63 crore in the quarter ended June 2025 as against Rs 288.58 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales347.63288.58 20 OPM %22.4722.63 - PBDT82.7471.14 16 PBT61.5360.14 2 NP43.8444.47 -1 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Jupiter Life Line Hospitals to announce Quarterly Result
Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Jupiter Life Line Hospitals to conduct AGM
Jupiter Life Line Hospitals announced that the 23th Annual General Meeting(AGM) of the company will be held on 11 July 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Board of Jupiter Life Line Hospitals recommends final dividend
Jupiter Life Line Hospitals announced that the Board of Directors of the Company at its meeting held on 9 May 2025, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live
10 months agoCapital Market - Live
Earnings
Jupiter Life Line Hospitals consolidated net profit declines 0.42% in the March 2025 quarter
Net profit of Jupiter Life Line Hospitals declined 0.42% to Rs 44.86 crore in the quarter ended March 2025 as against Rs 45.05 crore during the previous quarter ended March 2024. Sales rose 12.14% to Rs 326.74 crore in the quarter ended March 2025 as against Rs 291.38 crore during the previous quarter ended March 2024. For the full year,net profit rose 10.31% to Rs 193.20 crore in the year ended March 2025 as against Rs 175.14 crore during the previous year ended March 2024. Sales rose 17.52% to Rs 1261.55 crore in the year ended March 2025 as against Rs 1073.44 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales326.74291.38 12 1261.551073.44 18 OPM %23.9521.68 -23.5122.55 - PBDT79.7170.31 13 314.69237.80 32 PBT62.1059.92 4 257.70195.42 32 NP44.8645.05 0 193.20175.14 10 Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 22.65%, vs industry avg of 13.4%
Over the last 5 years, market share increased from 1.12% to 1.57%
Over the last 5 years, net income has grown at a yearly rate of 45.54%, vs industry avg of 42.46%